세계의 바이러스 검사 시장 보고서(2025년)
Virology Testing Global Market Report 2025
상품코드 : 1824485
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이러스 검사 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.0%로 성장할 전망이며, 87억 9,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 바이러스학에서 차세대 시퀀싱 채용, 기후 변화가 매개 바이러스의 확산에 미치는 영향, 모바일 및 재택 바이러스 검사 솔루션 대두, 바이러스 진단에서 디지털 병리학의 채용, 바이러스학 서베이런스에서 빅데이터 분석의 이용 증가 등에 기인하고 있습니다. 예측 기간 주요 동향으로는 분자 진단의 기술적 진보, 바이러스 검사에서 인공지능의 통합, 바이러스 검출을 위한 혁신적 바이오마커의 개발, 신규 항바이러스 요법 및 치료법의 개발, 지속가능하고 환경친화적인 검사 방법의 중시 등을 들 수 있습니다.

향후 5년간의 성장률 11.0%라고 하는 예측은 전회 예측으로부터 0.2%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 무역 마찰은 한국과 싱가포르에서 개발된 다중 중합효소 연쇄반응 분석 장치와 항원 검사 스트립의 가격을 상승시켜 아웃브레이크 봉쇄 지연 및 진단 시설의 비용 상승을 초래함으로써 미국의 팬데믹 대책에 지장을 초래할 수 있습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

바이러스 감염의 발생 증가는 향후 바이러스 검사 시장의 성장을 이끌 것으로 예측됩니다. 바이러스 감염은 바이러스에 의해 유발되는 질병이며, 바이러스는 단백질의 코팅에 싸여있는 유전 물질(DNA 또는 RNA)로 구성된 미세한 감염성 물질입니다. 바이러스 검사는 정확한 진단, 모니터링, 조사, 공중 보건 준비에 필수적입니다. 바이러스 병원체의 동정, 치료 전략에 대한 정보 제공, 감염 확대 추적, 새로운 개입책의 개발에 도움이 됩니다. 바이러스 검사에 대한 수요 증가는 바이러스 감염을 효과적으로 관리하고 그 영향을 완화할 필요성에 대한 대응입니다. 예를 들어, 2024년 9월 영국에 본사를 둔 정부 서비스 및 정보 제공업체인 GOV.UK는 2023년 40주부터 2024년 14주까지 영국에서 바이러스 검사 결과 SARS - CoV-2로 확인된 인플루엔자가 708건(53.3%), 인플루엔자가 472건(35.5%), RSV가 68건(5.1%), 기타 바이러스가 80건(6.0%)이었다고 보고했습니다. 따라서 바이러스 감염의 발병률이 증가하면 바이러스 검사 시장의 성장이 뒷받침됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Virology testing involves the diagnosis of viral infections by detecting the presence of viruses or specific viral components in biological samples such as blood, saliva, or tissue. These tests play a crucial role in identifying, monitoring, and controlling viral diseases.

The primary categories of virology testing include instruments, assay kits, and consumables. In the context of virology testing, instruments refer to specialized equipment and devices used for conducting various diagnostic tests and procedures. These tests utilize methods such as molecular diagnostics, immunoassays, mass spectrometry, and other techniques. Virology testing is applied in diverse areas, including the diagnosis of skin and soft tissue infections, respiratory tract infections, gastrointestinal tract infections, urinary tract infections, eye infections, sexually transmitted diseases, and perinatal infections. The end-users of virology testing include hospitals, clinics, laboratories, diagnostic centers, blood banks, and pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The virology testing research report is one of a series of new reports from The Business Research Company that provides virology testing market statistics, including the virology testing industry's global market size, regional shares, competitors with virology testing market share, detailed virology testing market segments, market trends and opportunities, and any further data you may need to thrive in the virology testing industry. This virology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The virology testing market size has grown strongly in recent years. It will grow from $5.39 billion in 2024 to $5.8 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to emergence of new and complex viruses, increase in infectious disease outbreaks, expansion of healthcare infrastructure, growing awareness of the importance of early virus detection, expansion of point-of-care virology testing options.

The virology testing market size is expected to see rapid growth in the next few years. It will grow to $8.79 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to adoption of next-generation sequencing in virology, impact of climate change on the spread of vector-borne viruses, rise of mobile and at-home virology testing solutions, adoption of digital pathology in virology diagnostics, increasing use of big data analytics for virology surveillance. Major trends in the forecast period include technological advancements in molecular diagnostics, integration of artificial intelligence in virology testing, development of innovative biomarkers for virus detection, development of novel antiviral therapies and treatments, emphasis on sustainable and eco-friendly testing methods.

The forecast of 11.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pandemic preparedness by inflating prices of multiplex Polymerase Chain Reaction analyzers and antigen test strips developed in South Korea and Singapore, resulting in delayed outbreak containment and higher diagnostic facility costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing occurrence of viral infections is projected to drive the growth of the virology testing market in the future. Viral infections are diseases caused by viruses, which are microscopic infectious agents made up of genetic material (DNA or RNA) encased in a protein coat. Virology testing is crucial for accurate diagnosis, monitoring, research, and public health readiness. It allows for the identification of viral pathogens, informs treatment strategies, tracks infection spread, and aids in developing new interventions. The growing demand for virology testing is a response to the necessity of effectively managing viral infections and mitigating their effects. For example, in September 2024, GOV.UK, a UK-based government services and information provider, reported that from week 40 of 2023 to week 14 of 2024 in England, virological testing results revealed 708 incidents (53.3%) confirmed as SARS-CoV-2, 472 incidents of influenza (35.5%), 68 incidents of RSV (5.1%), and 80 incidents (6.0%) involving other viruses. Hence, the rising incidence of viral infections is fueling the growth of the virology testing market.

The increase in healthcare expenditures is poised to contribute to the growth of the virology testing market in the future. Healthcare expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency assistance, with a primary focus on health. In virology testing, healthcare expenditures are essential for ensuring accurate diagnosis, monitoring, and containment of viral infections, thereby safeguarding public health and individual well-being. According to the Centers for Medicare & Medicaid Services, in December 2023, US healthcare spending witnessed a 4.1% increase in 2022, reaching $4.5 trillion, equivalent to $13,493 per person. Health spending accounted for 17.3% of the country's gross domestic product. Consequently, the rise in healthcare expenditures is a significant driver for the growth of the virology testing market.

Product innovation stands out as a prominent trend gaining traction in the virology testing market. Major players in the virology testing sector are actively introducing novel products to maintain their market positions. For instance, in November 2022, Italy-based medical equipment manufacturer Sentinel CH. SpA unveiled the SENTiNAT 200, a fully automated sample-to-result system, accompanied by the STAT-NAT SN200 Real-Time PCR assays capable of quantitatively detecting ten viruses. The SENTiNAT 200 platform integrates DNA and RNA extraction, PCR setup, and amplification, featuring two thermal cyclers and the FastFinder analysis software. Geared towards mid to large-throughput laboratories involved in viral infection diagnosis, the platform offers high throughput, automation, and flexibility. The user-friendly software, coupled with a barcode reader, reduces human error, and cloud-based data access optimizes reporting time and result control.

Major players in the virology testing market are directing their efforts toward advanced solutions, such as agar gel precipitation test solutions, to meet the growing demand for accurate diagnostic tools. These advanced solutions are specialized mixtures employed for intricate immunological analyses, specifically designed to detect and characterize antigen-antibody interactions. For instance, in May 2023, US-based biotechnology company Creative Diagnostics launched a new single radial immunodiffusion testing service tailored for the biological industry. This service streamlines the process for researchers to precisely assess the concentration of antigens within samples. Utilizing the well-established agar gel precipitation technique, the service employs antibodies with defined specificity uniformly distributed within the agar gel. By strategically placing samples containing the antigen of interest in wells within the gel, radial diffusion of the antigen occurs, leading to the formation of a distinct precipitate ring. This ring's diameter, accurately measured and referenced against a standard curve, enables the service to determine the antigen concentration, providing researchers with invaluable quantitative data.

In October 2022, Bio-Rad Laboratories Inc., a US-based research company, merged with QIAGEN N.V. for $10 billion. This merger allows Bio-Rad to enhance its portfolio by integrating QIAGEN's expertise in virology testing. QIAGEN N.V. is a Germany-based company known for providing PCR-based viral DNA and RNA tests.

Major companies operating in the virology testing market include Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., WuXi AppTec Co. Ltd., Hologic Inc., Sartorius AG, bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc, Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech plc, Diamedix Corporation, Biospherix Ltd, Imquest Biosciences Inc, Novogene Co Ltd., Scienion AG, Vircell SL

North America was the largest region in the virology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the virology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The virology testing market consists of revenues earned by entities by providing services such as comprehensive viral screening, virucidal disinfectant efficacy testing, virus research, and testing for infectious disease agents. The market value includes the value of related goods sold by the service provider or included within the service offering. The virology testing market also includes sales of virology test kits, polymerase chain reaction (PCR) instruments, and enzyme-linked immunosorbent assay (ELISA) kits, which are used in providing virology testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on virology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for virology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The virology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Virology Testing Market Characteristics

3. Virology Testing Market Trends And Strategies

4. Virology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Virology Testing Growth Analysis And Strategic Analysis Framework

6. Virology Testing Market Segmentation

7. Virology Testing Market Regional And Country Analysis

8. Asia-Pacific Virology Testing Market

9. China Virology Testing Market

10. India Virology Testing Market

11. Japan Virology Testing Market

12. Australia Virology Testing Market

13. Indonesia Virology Testing Market

14. South Korea Virology Testing Market

15. Western Europe Virology Testing Market

16. UK Virology Testing Market

17. Germany Virology Testing Market

18. France Virology Testing Market

19. Italy Virology Testing Market

20. Spain Virology Testing Market

21. Eastern Europe Virology Testing Market

22. Russia Virology Testing Market

23. North America Virology Testing Market

24. USA Virology Testing Market

25. Canada Virology Testing Market

26. South America Virology Testing Market

27. Brazil Virology Testing Market

28. Middle East Virology Testing Market

29. Africa Virology Testing Market

30. Virology Testing Market Competitive Landscape And Company Profiles

31. Virology Testing Market Other Major And Innovative Companies

32. Global Virology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Virology Testing Market

34. Recent Developments In The Virology Testing Market

35. Virology Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기